This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Stratified cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): impact of varying metabolic risk factor burden
European Journal of Medical Research Open Access 23 September 2025
-
Analysis of effector/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis
Cell Death & Disease Open Access 11 February 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Tsui, H. et al. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy. Sci. Transl. Med. 15, eadd4248 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huynh, K. Increased degradation of desmosomal proteins in ACM. Nat Rev Cardiol 20, 371 (2023). https://doi.org/10.1038/s41569-023-00874-2
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41569-023-00874-2
This article is cited by
-
Stratified cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): impact of varying metabolic risk factor burden
European Journal of Medical Research (2025)
-
Analysis of effector/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis
Cell Death & Disease (2025)